CorMedix Inc. CRMD

Updated: 9 Aug 2026

NASDAQ | Biotech | Biotechnology and pharmaceuticals

No signal published yet

We already track CorMedix and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow CorMedix free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Biotechnology and pharmaceuticals
We're already tracking CorMedix Inc. — here are the latest events we've registered

Recent News

  • In August 2026, CorMedix received preliminary court approval for a settlement of a shareholder derivative lawsuit. In May 2026, the company reported first-quarter revenue of $127.4 million and raised its full-year guidance. CorMedix is scheduled to report its second-quarter 2026 financial results on August 13, 2026.

What Firelda Watch includes for CorMedix Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of CorMedix Inc. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Hansa Biopharma AB (publ)
HNSA
HOLD
Bioarctic
BIOA B
BUY
Recipharm
RECI B
NEUTRAL
Viatris Inc.
VTRS
HOLD
Sprint Bioscience AB (publ)
SPRINT
NEUTRAL

Biotech

More companies in this sector

Want to follow CorMedix Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow CorMedix free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

CorMedix Inc. CRMD
CorMedix — follow and we'll monitor it
Follow CorMedix free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.